Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Bill J. Smith, Jennifer Tang et al.|Molecular Pharmaceutics|2023Cited by 52
A potent nuclear export mechanism imposes USP16 cytoplasmic localization during interphaseNadine Sen Nkwe, El Bachir Affar, Helen Yu et al.|Journal of Cell Science|2020Cited by 22
Discovery ofLenacapavir: First-in-Class Twice-YearlyCapsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, John O. Link, Winston C. Tse et al.|Journal of Medicinal Chemistry|2025Cited by 11